The NIAID is enrolling participants in its ACTT-4 clinical trial to assess the effectiveness of dexamethasone plus remdesivir, compared to baricitinib plus remdesivir.
A new study from Israel indicates that hyperbaric oxygen treatments in healthy aging adults can stop the aging of blood cells.
Patients' last days of COPD can be characterized by depression, anxiety, pain, and dyspnea. Clinicians must be alert to patient discomfort and offer appropriate palliative care and reassurance.
Survey confirms COVID-19 pandemic impacted ability of COPD patients and informal caregivers to receive and administer care, but brought increased awareness to the disease.
The FDA issued an EUA for the drug baricitinib in combination with remdesivir to treat patients age two and older who are hospitalized COVID-19.
High PEEP titration and prone positioning were as effective in treating early COVID-19 ARDS patients undergoing mechanical ventilation as classic ARDS.
People of color diagnosed with lung cancer face worse outcomes compared to white Americans, according to the American Lung Association’s third annual State of Lung Cancer report.
According to Repair Authority, CPAP Medic is the only CPAP repair and maintenance service targeted specifically to the patient market.